English Monthly for New Drug Candidates
English Monthly for New Drug Candidates
Recent publications of Keiji Nakamura, Ph.D., Pharma Forum Institute
Diabetes and obesity: Review in the period between April 2009 and March 2010
New Drug Candidates Vol 21 No 3 pp1-151 April 2010 Pharmaceutical licensing contracts
New Drug Candidates Vol 21 No 2 pp129-155 March 2010 Dalcetrapib seen topping list of Japanese-origin blockbusters
Scrip News February 18 2010 Prospect of Japanese pharmaceutical industry in 2010 Pharma Japan No 2176 pp14-19 February 15 2010 R&D activity of Japanese Pharmaceutical companies in 2010 New Drug Candidates Vol 20 No 9 pp1-226 December 2009 Pharmacology of aging and longevity: looking for anti-aging therapeutics
Pharma Japan No 2152 pp16-19 November 2 2009Pharmacology of aging and longevity: looking for anti-aging therapeutics Pharma Japan No 2152 pp16-19 November 2 2009 Cancer special issues New Drug Candidates Vol 20 No 7 pp1-252 September 2009 Annual sales and main drugs in Japanese pharmaceutical companies in 2008 from 2002 New Drug Candidates Vol 20 No 6 pp179-230 July 2009 Biomarkers and related topics New Drug Candidates Vol 20 No 5 pp1-123 June 2009 Annual sales of main drugs and R&D cost of international majors in 2008 from 2004 New Drug Candidates Vol 20 No 3 pp181-229 April 2009 Diabetes and obesity New Drug Candidates Vol 20 No 3 pp1-180 April 2009 Japanese pharmaceutical companies: blockbusters, candidates and pipelines
New Drug Candidates Vol 19 No 11 pp293-378 January 2009 Patent expiration of blockbusters, and new breakthrough candidates from Japanese Pharmaceutical companies
Pharma Japan No 2126 pp12-6 February 9 2009 Pharmaceutical licensing contracts of Japanese pharmaceutical companies and others New Drug Candidates Vol 20 No 2 pp-177-197 2009 Prasugrel to lead Japan-origin blockbusters (cited)
SCRIP World Pharmaceutical News February 10 2009 Diabetes and obesity: recent research and topics
New Drug Candidates Vol 20 No 3 pp1-180 2009 International majors: drug sales in 2004 – 2008 New Drug Candidates Vol 20 No 3 pp181-229 2009 Biomarkers: research and development in Jan 2007 – May 2009 New Drug Candidates Vol 20 No 5 pp1-123 2009 Recent R&D activities of Japanese pharmaceutical companies New Drug Candidates Vol 19 No 10 2008 Recent R&D activities of international pharmaceutical majors New Drug Candidates Vol 19 No 9 2008 Prasugrel tops predicted Japan blockbusters SCRIP No.3347 page 20-21, March 25 2008 Current new drug development in the Japanese pharmaceutical industry
Pharma Japan No.2077 pp12-18 February 11 2008 Anticancer drugs and candidates under development of pharmaceutical
companies in the worldNew Drug Candidates Vol 18 No 7 pp1-452 July 2007 Prasugrel heads up potential Japanese-origin blockbusters
SCRIP No.3238 page 14 March 2nd 2007 Breakthrough candidates of Japanese pharmaceutical companies Pharma Japan No.2028 pp10-16 February 12 2007 New Drug Candidates 17 pp319-379 January 2007 News from the Japanese Pharma Licensing Association (JPLA) Business Development & Licensing Journal, UK pp4-5, Autumn 2006 Blockbuster sales of international majors in 2005: rankings of companies and therapeutic areas
Pharma Japan No.2004, pp 13-17 August 14 & 21
New Drug Candidates 17 No.3 pp175-195 April 2006Prasugrel set to top Japanese blockbusters SCRIP No.3140 page No. p24 March 14 2006 Blockbuster candidates from Japanese pharmaceutical companies in 2006 Pharma Japan extra issue No.1988 April 17 2006
New Drug Candidates 16 No.11 pp315-323 January 2006Vascular calcification, ultimate consequence of vascular atherosclerosis New Drug Candidates 16 No.183-191 December 2005
Pharma Japan No.1976 pp12-15, ibid No.1977 pp12-14 2006A cluster of diseases, “metabolic syndrome”, reflecting on aging society New Drug Candidates 16 No.7 pp196-202 September 2005, and
Pharma Japan No.1965 pp15-18 October 31 2005,
ibid No.1966 pp12-13 Nov 7 2005Type 2 diabetes mellitus: expanding therapeutic strategy New Drug Candidates 16 No.4 pp203-214 May 2005, and
Pharma Japan No.1947 pp17-20 June 20 2005;
ibid No.1948 pp16-17 June 27 2005;
ibid No.1949 pp13-15 July 4 2005
Blockbuster candidates from Japanese pharmaceutical companies in 2005
New Drug Candidates 15 No.11 pp313-316 January 2005. Emerging new therapeutics against hypercholesterolemia and atherosclerosis: Lipitor, a golden standard ?
New Drug Candidates 15 No.10 pp191-195 December 2004.
  |
